News Helix BioPharma Corp.

Equities

HBP

CA4229101098

Market Closed - Toronto S.E. Other stock markets 02:13:49 2024-04-17 pm EDT			5-day change	1st Jan Change
0.175 ^CAD	-12.50%		-5.41%	-16.67%

Apr. 08	Helix BioPharma Corp. announced that it has received CAD 1.915 million in funding	CI
Mar. 28	Helix BioPharma Corp. announced that it expects to receive CAD 1.915 million in funding	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Helix BioPharma Corp. announced that it has received CAD 1.915 million in funding	Apr. 07	CI
Canadian Investment Regulatory Organization Trade Resumption - HBP	Apr. 01	AQ
Canadian Investment Regulatory Organization Trading Halt - HBP	Mar. 28	AQ
Helix BioPharma Corp. announced that it expects to receive CAD 1.915 million in funding	Mar. 27	CI
North American Morning Briefing : Markets Steady -2-	Mar. 26	DJ
Helix BioPharma Corp. Appoints Praveen Varshney as Corporate Secretary	Feb. 13	CI
Helix BioPharma Corp. Appoints Praveen Varshney as Chief Financial Officer	Feb. 13	CI
Helix BioPharma Corp. Reports Voting Results	Jan. 18	AQ
North American Morning Briefing : S&P 500 Eyes Record High as Rate Cut Hopes Underpin Sentiment	Dec. 19	DJ
Helix Biopharma: Fiscal Q1 Earnings Snapshot	Dec. 14	AQ
Helix BioPharma Corp. Reports Earnings Results for the First Quarter Ended October 31, 2023	Dec. 14	CI
Helix BioPharma Corp. Announces Fiscal 2024 First Quarter Results	Dec. 14	AQ
North American Morning Briefing : Traders Eye -2-	Dec. 12	DJ
Helix BioPharma : Announces Closing of Private Placement of CAD $3 Million and Board Changes	Nov. 02	PU
Helix Biopharma: Fiscal Q4 Earnings Snapshot	23-10-27	AQ
Helix BioPharma Corp. Reports Earnings Results for the Full Year Ended July 31, 2023	23-10-27	CI
Helix Biopharma Corp. Announces Fiscal 2023 Year-End Results	23-10-27	AQ
Helix BioPharma Corp. announced that it has received CAD 2.998 million in funding	23-10-26	CI
Helix BioPharma Corp. to Present New Preclinical Data on L-DOS47 in Combination with PD1 Checkpoint Inhibitor at the 2023 AACR- NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics	23-10-10	CI
Helix Biopharma Announces Upcoming Poster Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics	23-10-10	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Helix BioPharma Corp.

Equities

HBP

CA4229101098

Summary

Filters